# Novo Nordisk Pharmaceuticals, Inc.

- Location (FDA's records): Princeton, NJ
- FDA decisions: 2 (1993–1995): 2 510(k) clearances
- Product codes: FMF (2)
- Predicates its devices cite: 0 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms that cite its devices most
- Disetronic Medical Systems: 1 (https://510kreport.com/company/disetronic-medical-systems)

## Its most-cited devices
- K942159: Novopen 1.5 (1995), cited by 1

## Recent decisions
- K942159: Novopen 1.5 (Apr 26, 1995)
- K921908: Novolinpen Dial-a-Dose Insulin Delivery Device (Jun 29, 1993)

Source page: https://510kreport.com/company/novo-nordisk-pharmaceuticals
